Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.co.in
Get the latest updates from Google Alert - tezepelumab directly as they happen.
Follow now 110 followers
Last updated about 17 hours ago
about 19 hours ago
... tezepelumab attempts. The Phase 1 proof-of-mechanism study in mild-to-moderate asthma, using...
about 22 hours ago
The drug – licensed from China's Kelun-Biotech – is aiming to compete...
1 day ago
Für Tezepelumab, das nun neu zugelassen ist als Add-on-Therapie mit intranasalen Corticoidsteroiden...
2 days ago
Tezepelumab: Amgen/AstraZeneca. TEZSPIRE (tezepelumab-ekko) is a human monoclonal antibody administered through subcutaneous...
2 days ago
... tezepelumab” sejak 2024, tahap kesihatannya kini semakin stabil. Pada masa sama...
2 days ago
... Tezepelumab bagi membantu pesakit asma kronik mengawal penyakit dengan lebih berkesan...
2 days ago
However, her condition became more stable in 2024 after she started taking...
4 days ago
The diagnosis is based on clinical examination, pulmonary function tests, biomarker analysis...
5 days ago
Since the 2021 approval of AstraZeneca and Amgen's Tezspire (tezepelumab) as an...
7 days ago
bone (@boneGPT). 8 likes 642 views. Grok says there are new biologics...
8 days ago
Tezepelumab, a human monoclonal antibody targeting thymic stromal lymphopoietin (TSLP), has demonstrated...
8 days ago
... tezepelumab-ekko (Tezspire), procedure code J2356, as an add-on maintenance treatment for...